| Class 2 Device Recall Tinaquant Hemoglobin A1c Gen.2 |  |
Date Initiated by Firm | October 04, 2016 |
Date Posted | November 11, 2016 |
Recall Status1 |
Terminated 3 on June 05, 2017 |
Recall Number | Z-0395-2017 |
Recall Event ID |
75366 |
510(K)Number | K072714 |
Product Classification |
Assay, glycosylated hemoglobin - Product Code LCP
|
Product | Tina-Quant Hemoglobin A1c Gen. 2
Hemoglobin A1c test
Catalog number 04528123190 / 05401640190 |
Code Information |
Not applicable |
Recalling Firm/ Manufacturer |
Roche Diagnostics Operations, Inc. 9115 Hague Rd Indianapolis IN 46256-1025
|
For Additional Information Contact | Roche Support Network Customer Support C 800-428-2336 |
Manufacturer Reason for Recall | Roche Diagnostics has confirmed elevated QC and patient sample recovery for individual
Tina-quant Hemoglobin A1c Gen.2 and Tina-quant Hemoglobin A1cDx Gen.2 cassettes/bottles.
This issue occurred over multiple lots. Single cassettes/bottles of the reagents are affected.
The issue can lead to erroneously high HbA1c results. If a patient with known diabetes is affected,
an erroneously high HbA1c result might lead to therapeutic consequences, such as therapy escalation
(introduction of another oral antidiabetic medication or insulin) or increase of the dosage. This can
further lead to an increased risk of hypoglycemia. Considering the unreliable detectability of the issue,
relevant medical risk for the patient cannot entirely be excluded. |
FDA Determined Cause 2 | Storage |
Action | On 10/4/2016, URGENT MEDICAL DEVICE CORRECTION notifications were sent to the affected Direct Consignees and Distributors via courier. The recall notifications included a description of the reason for the recall, affected product, consignee responsibilities, and instructions for responding to the formal recall notification.
Direct Consignee
Actions Required
" Follow the instructions in the Customer Actions for Prevention/Detection of the Issue section of this Urgent Medical Device Correction (UMDC).
" Complete the attached fax form (7184-00-1016) and fax it to 1-844-294-7181.
" File this Urgent Medical Device Correction (UMDC) for future reference.
Questions
Please contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week
at 1-800-428-2336 if you have questions about the information contained in this UMDC.
Distributor
Actions Required
" Ensure proper storage conditions (2-8C) are maintained for the reagents listed in the table above,
per their respective method sheet.
" If you have not directly shipped any of the products in the table above, you do not need to distribute
the enclosed UMDC to your customers.
" If you have directly shipped any of the products in the table above, please distribute the enclosed
UMDC 16-157 to those customers.
" Complete the attached fax form (7185-00-1016) and fax it to 1-844-294-7181.
Questions
Please contact the Roche Support Network Customer Support Center at 1-800-428-2336 if you have
questions about the information contained in this distributor letter or the enclosed UMDC 16-157. |
Quantity in Commerce | 4976 |
Distribution | Nationwide. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = LCP
|
|
|
|